FDA: Librela Tied to 3,600+ Dog Adverse Reactions, Deaths

Karmactive Staff

Photo Source:- Pixbay (Pexels)

The FDA issued a warning regarding Librela, a dog arthritis medication, following more than 3,600 reports of serious adverse reactions, including deaths.

Ataxia, seizures, partial paralysis, and urinary complications are among the reported side effects.

Photo Source:- Lisa Fotios (Pexels)

Photo Source:- Time Miroshnichenko (Pexels)

Librela, approved by the FDA in May 2023, is a monthly treatment for canine osteoarthritis.

Devastating results, including kidney failure and euthanasia, have been reported by pet owners following treatment with Librela.

Photo Source: Valeria Boltneva (Pexels)

Photo Source:- Smithsonian Institution Traveling Exhibition Service (CC BY-NC-ND 2.0)

Manufacturer Zoetis defends the safety of Librela, saying that adverse effects occur very rarely, in a population of 21 million doses distributed worldwide.

Veterinarians are encouraged to make careful diagnoses and discuss the risks with pet owners before prescribing.

Photo Source:- International Fund for Animal Welfare

Photo Source:- PICRYL

The FDA advises labeling on Librela and that it urgently reports any events to it.

The FDA with the statistics showing that 14 million U.S. dogs are suffering from osteoarthritis asks pet owners to see veterinarians for less risky alternatives.

Photo Source:- Blue Bird (Pexels)